Overview

PRAXBIND® is a specific reversal agent for dabigatran. PRAXBIND® is indicated in adult patients treated with PRADAXA® when rapid reversal of the anticoagulant effects of dabigatran is required.

Product overview

PRAXBIND® is a specific reversal agent for PRADAXA®.

product_key2

Indication

PRAXBIND® is a specific reversal agent for dabigatran and is indicated in adult patients treated with PRADAXA® when rapid reversal of the anticoagulant effects of dabigatran is required:

  • For emergency surgery/urgent procedures
  • In life-threatening or uncontrolled bleeding
product_key3

Active ingredients

Idarucizumab

product_key4

Legal category

Prescription only medicine

product_Key7

Administration form

Intravenous bolus or infusion

product_key6

Dosage form

Solution for injection/infusion

product_key1

Pack sizes

50 mL solution in a glass vial (type I glass), with a butyl rubber stopper, an aluminum cap and a label with integrated hanger.
Pack size of 2 vials.

product_key5

Storage

Store in a refrigerator (2 °C-8 °C).
Do not freeze.
Store in the original package in order to protect from light.

Prior to use, the unopened vial may be kept at room temperature (25 °C) for up to 48 hours, if stored in the original package in order to protect from light, or up to 6 hours when exposed to light.

Reference:

  1. PRAXBIND® approved package insert. Updated in May 2019 and approved in November 2019.

Please be aware that this website contains promotional information about Boehringer Ingelheim medicines and services. Some of this may not be directly relevant to your scope of practice and it is your own decision whether you choose to view this information.